Physician profile
Steven C Baker
NPI 1972966570
$1,502.61
in general payments reported to CMS, 2019-2025
13 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $83.04 · 2022: $157 · 2023: $1,102 · 2024: $59.06 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $738 · Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $737.88 |
| Food and Beverage | $525.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,146.55 | 2022-2023 | Comprehensive Shoulder System, Choice Instruments |
| Radius Health, INC. | $59.06 | 2024 | Tymlos |
| Ermi LLC | $53.09 | 2021-2025 | |
| Skeletal Dynamics INC | $48.40 | 2021 | |
| Janssen Pharmaceuticals, INC | $31.01 | 2022 | |
| Molnlycke Health Care US, LLC | $28.89 | 2025 | Mepilex Border Post-Op Ag, Mepilex Border Post-Op |
| Kowa Pharmaceuticals America, INC. | $28.34 | 2023 | Seglentis |
| Ethicon US, LLC | $23.72 | 2025 | Dermabond Prineo, Stratafix, Ethicon |
| Vertex Pharmaceuticals Incorporated | $20.90 | 2025 | |
| Endo Pharmaceuticals INC. | $17.30 | 2022 | |
| Bioventus LLC | $16.85 | 2025 | Exogen Ultrasound Bone Healing System |
| Medical Device Business Services, INC. | $15.09 | 2021 | |
| Amgen INC. | $13.41 | 2023 | Prolia, Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.